TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.390
+0.070 (1.62%)
May 1, 2026, 4:00 PM EDT - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $269.61 million as of May 4, 2026. Its market cap has increased by 45.80% in one year.
Market Cap
269.61M
Enterprise Value
283.61M
1-Year Change
45.80%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $269.61M, a decrease of -17.99%. That is a compound annual growth rate of -3.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 269.61M | -22.69% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ClearPoint Neuro | 340.94M |
| RxSight | 305.37M |
| 908 Devices | 254.56M |
| Profound Medical | 243.19M |
| Sight Sciences | 242.10M |
| Senseonics Holdings | 213.20M |
| Electromed | 211.85M |
| CVRx, Inc. | 210.65M |